Enedra Therapeutics
3 known investors
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.
Investors · 3
Frequently asked questions
- What does Enedra Therapeutics do?
- Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.
- Who are Enedra Therapeutics's investors?
- Enedra Therapeutics's investors include Deep Science Ventures, KU Leuven Research & Development, O2h Ventures.